1. Home
  2. OCSL vs SLS Comparison

OCSL vs SLS Comparison

Compare OCSL & SLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oaktree Specialty Lending Corporation

OCSL

Oaktree Specialty Lending Corporation

HOLD

Current Price

$11.69

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo SELLAS Life Sciences Group Inc.

SLS

SELLAS Life Sciences Group Inc.

HOLD

Current Price

$12.39

Market Cap

924.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OCSL
SLS
Founded
2007
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
924.5M
IPO Year
2007
2007

Fundamental Metrics

Financial Performance
Metric
OCSL
SLS
Price
$11.69
$12.39
Analyst Decision
Hold
Strong Buy
Analyst Count
4
1
Target Price
$12.63
$10.00
AVG Volume (30 Days)
578.4K
7.9M
Earning Date
05-05-2026
05-11-2026
Dividend Yield
12.73%
N/A
EPS Growth
N/A
50.00
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.31
$110.98
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.63
$1.39
52 Week High
$14.77
$11.06

Technical Indicators

Market Signals
Indicator
OCSL
SLS
Relative Strength Index (RSI) 45.19 77.80
Support Level $11.01 $3.72
Resistance Level $12.26 N/A
Average True Range (ATR) 0.26 0.80
MACD -0.03 0.29
Stochastic Oscillator 34.93 96.23

Price Performance

Historical Comparison
OCSL
SLS

About OCSL Oaktree Specialty Lending Corporation

Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets. The company operates as a single reportable segment and derives revenues from investing in originated loans and other securities, including broadly syndicated loans, of U.S. private companies and manages the business on a consolidated basis.

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

Share on Social Networks: